Page last updated: 2024-08-24

emitefur and Colorectal Neoplasms

emitefur has been researched along with Colorectal Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eng, C; Kindler, HL; Schilsky, RL	1
Fujita, F; Fujita, M; Inaba, H; Taguchi, T	1
Brito, RA; Hoff, PM; Medgyesy, D; Pazdur, R; Ravandi-Kashani, F; Royce, ME; Zukowski, TH	1
Brito, R; Hoff, PM; Medgyesy, D; Pazdur, R; Royce, M	1
Fujii, S; Fujita, F; Fujita, M; Fukushima, M; Shirasaka, T; Taguchi, T	1

Reviews

3 review(s) available for emitefur and Colorectal Neoplasms

Article	Year
Oral fluoropyrimidine treatment of colorectal cancer. Clinical colorectal cancer, 2001, Volume: 1, Issue:2 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Patient Compliance; Prodrugs; Pyridines; Tegafur; Treatment Outcome	2001
Fluoropyrimidines: a critical evaluation. Oncology, 1999, Volume: 57 Suppl 1 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Leucovorin; Oxonic Acid; Pyridines; Tegafur; Uracil	1999
Oral fluoropoyrimidines. Seminars in oncology, 1999, Volume: 26, Issue:6 Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Folic Acid Antagonists; Humans; Leucovorin; Oxidoreductases; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil	1999

Other Studies

2 other study(ies) available for emitefur and Colorectal Neoplasms

Article	Year
[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil	1993
[Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9 Topics: Administration, Oral; Animals; Antineoplastic Agents; Colorectal Neoplasms; Fluorouracil; Humans; Liver; Mice; Mice, Nude; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Stomach Neoplasms	1990

Article

Year

[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].

Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2

Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil

1993

[Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].

Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

Topics: Administration, Oral; Animals; Antineoplastic Agents; Colorectal Neoplasms; Fluorouracil; Humans; Liver; Mice; Mice, Nude; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Stomach Neoplasms

1990